IN THE NEWS
Longfin Corp (NASDAQ: LFIN) stock has
been all over the map lately, plummeting 80 percent in a two-week stretch before surging 80 percent Thursday after CNBC interviewed
CEO Venkat Meenavalli:
Link
The market-moving nature of clinical trial results is due to the fact that only a small proportion of drugs that move from
pre-clinical trials or animal testing stage advance successfully through the three phases of clinical trials:
Link
President Donald Trump threatened a major escalation in trade tensions with Beijing on Thursday, saying he was considering
imposing tariffs on an additional $100 billion in imports from China:
Link $
Stock-market swings in the past week have many investors scrambling to profit from the return of turbulence after a prolonged
period of tranquility:
Link $
U.S. job growth slowed in March as the boost from mild temperatures faded:
Link
Special Counsel Robert Mueller revealed to lawyers for Paul Manafort, the former Trump campaign chairman, that they obtained a
search warrant for information about five telephone numbers, suggesting the sprawling investigation may be headed in a new
direction:
Link
MGM Resorts (NYSE: MGM) has expressed
recent interest in buying Wynn Resorts (NASDAQ: WYNN), The Post has learned:
Link
ECONOMIC DATA
- Nonfarm Payrolls for Mar 103.0K vs 193.0K Est; Prior 313.0K. Private Payrolls for Mar 102.0K vs 190.0K Est; Prior 287.0K
- Unemployment Rate for Mar 4.10% vs 4.00% Est; Prior 4.10%
- Chicago Federal Reserve Bank President Charles Evans is set to speak in Chicago at 10:30 a.m. ET.
- The Baker Hughes North American rig count report for the latest week is schedule for release at 1:00 p.m. ET.
- Federal Reserve Chairman Jerome Powell will speak in Chicago at 1:30 p.m. ET.
- Data on consumer credit for February will be released at 3:00 p.m. ET.
- San Francisco Federal Reserve Bank President John Williams is set to speak in Santa Rosa, California at 4:00 p.m. ET.
ANALYST RATINGS
- Mizuho upgraded Valeant (NYSE: VRX) from
Underperform to Neutral
- KeyBanc upgraded Halyard Health (NYSE: HYH) from Sector Weight to Overweight
- JPMorgan downgraded Xilinx (NASDAQ: XLNX) from Neutral to Underweight
This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five
minutes. To get the full version of this note every morning, click
here.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.